Prothena plc (PRTA) Touches $38.49 Formed H&S; Last Week Vuzix (VUZI) Analysts

Vuzix Corporation (NASDAQ:VUZI) Logo

Among 5 analysts covering Vuzix (NASDAQ:VUZI), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vuzix had 17 analyst reports since August 17, 2015 according to SRatingsIntel. Chardan Capital Markets maintained Vuzix Corporation (NASDAQ:VUZI) on Tuesday, December 26 with “Buy” rating. The firm has “Buy” rating by Maxim Group given on Friday, November 10. On Thursday, December 10 the stock rating was initiated by H.C. Wainwright with “Buy”. The rating was maintained by Maxim Group with “Buy” on Wednesday, August 2. The firm has “Buy” rating by Maxim Group given on Tuesday, March 20. The company was reinitiated on Monday, September 28 by Chardan Capital Markets. The firm has “Buy” rating by Chardan Capital Markets given on Monday, January 8. The stock of Vuzix Corporation (NASDAQ:VUZI) has “Buy” rating given on Monday, January 8 by Craig Hallum. The rating was downgraded by Zacks to “Hold” on Friday, August 21. Maxim Group maintained the shares of VUZI in report on Tuesday, January 30 with “Buy” rating. See Vuzix Corporation (NASDAQ:VUZI) latest ratings:

20/03/2018 Broker: Maxim Group Old Rating: Buy New Rating: Buy Old Target: $13 New Target: $11 Maintain
30/01/2018 Broker: Maxim Group Rating: Buy New Target: $13.0 Maintain
08/01/2018 Broker: Chardan Capital Markets Rating: Buy New Target: $10.0 Maintain
08/01/2018 Broker: Craig Hallum Rating: Buy New Target: $12.0 Initiate
26/12/2017 Broker: Chardan Capital Markets Rating: Buy New Target: $10.0 Maintain
10/11/2017 Broker: Maxim Group Rating: Buy New Target: $11.0 Maintain

Prothena Corporation plc (PRTA) formed inverse H&S with $40.41 target or 5.00% above today’s $38.49 share price. Prothena Corporation plc (PRTA) has $1.48 billion valuation. The stock increased 1.08% or $0.41 during the last trading session, reaching $38.49. About 352,056 shares traded. Prothena Corporation plc (NASDAQ:PRTA) has declined 31.00% since April 18, 2017 and is downtrending. It has underperformed by 42.55% the S&P500.

Among 14 analysts covering Prothena Corp (NASDAQ:PRTA), 13 have Buy rating, 0 Sell and 1 Hold. Therefore 93% are positive. Prothena Corp has $100 highest and $50 lowest target. $75.27’s average target is 95.56% above currents $38.49 stock price. Prothena Corp had 33 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Prothena Corporation plc (NASDAQ:PRTA) has “Buy” rating given on Monday, December 4 by Oppenheimer. The company was maintained on Thursday, April 5 by Barclays Capital. Wedbush downgraded the stock to “Neutral” rating in Monday, November 20 report. The stock has “Buy” rating by Suntrust Robinson on Wednesday, December 21. On Thursday, February 15 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The rating was initiated by Credit Suisse with “Outperform” on Thursday, January 21. As per Thursday, November 2, the company rating was maintained by RBC Capital Markets. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, September 28. The stock of Prothena Corporation plc (NASDAQ:PRTA) earned “Buy” rating by BTIG Research on Friday, September 29. The stock of Prothena Corporation plc (NASDAQ:PRTA) has “Buy” rating given on Wednesday, March 21 by Oppenheimer.

Analysts await Prothena Corporation plc (NASDAQ:PRTA) to report earnings on May, 8. They expect $-1.24 EPS, down 25.25% or $0.25 from last year’s $-0.99 per share. After $-1.24 actual EPS reported by Prothena Corporation plc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Investors sentiment decreased to 1.18 in 2017 Q4. Its down 0.47, from 1.65 in 2017Q3. It is negative, as 29 investors sold Prothena Corporation plc shares while 32 reduced holdings. 28 funds opened positions while 44 raised stakes. 31.32 million shares or 0.27% more from 31.24 million shares in 2017Q3 were reported. Mufg Americas Holdg reported 97 shares or 0% of all its holdings. Citadel Ltd Liability Com has 0% invested in Prothena Corporation plc (NASDAQ:PRTA) for 66,868 shares. Stratos Wealth Prtn Limited stated it has 0% in Prothena Corporation plc (NASDAQ:PRTA). Eventide Asset Mgmt Limited Liability Corporation holds 0.23% or 120,000 shares. Focused Wealth Mgmt, New York-based fund reported 6,150 shares. Tower Capital Llc (Trc) stated it has 579 shares or 0% of all its holdings. Carroll has 0% invested in Prothena Corporation plc (NASDAQ:PRTA). Wells Fargo And Mn reported 27,754 shares. 22,150 were reported by Dekabank Deutsche Girozentrale. California State Teachers Retirement reported 60,534 shares or 0% of all its holdings. Atlantic Tru Grp Inc Inc Limited Liability Company holds 137 shares. Cornerstone Advisors Inc stated it has 0% in Prothena Corporation plc (NASDAQ:PRTA). Fisher Asset Limited Liability Com invested in 27,485 shares or 0% of the stock. Meeder Asset Management owns 108 shares for 0% of their portfolio. The Massachusetts-based Winslow Evans Crocker has invested 0% in Prothena Corporation plc (NASDAQ:PRTA).

Since December 14, 2017, it had 5 insider purchases, and 0 sales for $117,730 activity. Shares for $23,555 were bought by Boris Paul A. Harned Timothy Heydenreich also bought $15,020 worth of Vuzix Corporation (NASDAQ:VUZI) on Thursday, December 14. 5,000 Vuzix Corporation (NASDAQ:VUZI) shares with value of $30,495 were bought by Russell Grant. Travers Paul J bought $19,940 worth of Vuzix Corporation (NASDAQ:VUZI) on Monday, March 26.

The stock increased 9.92% or $0.6 during the last trading session, reaching $6.65. About 937,167 shares traded or 12.43% up from the average. Vuzix Corporation (NASDAQ:VUZI) has declined 2.48% since April 18, 2017 and is downtrending. It has underperformed by 14.03% the S&P500.

Vuzix Corporation designs, manufactures, markets, and sells wearable display devices in the United States and internationally. The company has market cap of $181.55 million. The companyÂ’s products are worn like eyeglasses that enable the user to view video and digital content, such as movies, computer data, the Internet, or video games. It currently has negative earnings. The Company’s products include binocular wearable displays that contain two micro displays mounted in a frame attached to eyeglass-style temples or stereo headphones; monocular smart glasses products for the enterprise, industrial, and commercial markets, as well as video headphones; augmented reality products, which provide the user a live, direct or indirect, view of a physical, and real-world environment; and video viewing glasses as mobile displays for entertainment and gaming for on-the-go users, as well as support for stepping into virtual worlds, simulations, and virtual reality gaming.

Investors sentiment increased to 3 in Q4 2017. Its up 1.91, from 1.09 in 2017Q3. It increased, as 3 investors sold Vuzix Corporation shares while 4 reduced holdings. 10 funds opened positions while 11 raised stakes. 2.06 million shares or 12.84% more from 1.83 million shares in 2017Q3 were reported. Valley National Advisers holds 0% of its portfolio in Vuzix Corporation (NASDAQ:VUZI) for 1,000 shares. Gsa Partners Llp has 27,900 shares. Susquehanna Int Limited Liability Partnership has invested 0% in Vuzix Corporation (NASDAQ:VUZI). Asset Mngmt Inc holds 12,500 shares or 0.01% of its portfolio. Goldman Sachs Gp Inc has 0% invested in Vuzix Corporation (NASDAQ:VUZI). 9,255 are owned by Barclays Public Limited Co. Raymond James & Associate invested in 0% or 28,615 shares. Citadel Advsr stated it has 0% in Vuzix Corporation (NASDAQ:VUZI). 102,203 are held by Geode Cap Mgmt Llc. Lpl Financial Ltd Limited Liability Company, California-based fund reported 19,011 shares. Morgan Stanley holds 0% in Vuzix Corporation (NASDAQ:VUZI) or 13,303 shares. 15,120 are owned by Virtu Financial Limited Liability Com. 5,700 are held by Qci Asset Mngmt Incorporated. Bankshares Of Montreal Can reported 244,400 shares or 0% of all its holdings. Tower Cap Limited Liability Company (Trc) holds 0% or 1,464 shares.

Vuzix Corporation (NASDAQ:VUZI) Institutional Positions Chart